Cargando…
Hepatitis C in European prisons: a call for an evidence-informed response
Globally, over 10 million people are held in prisons and other places of detention at any given time. People who inject drugs (PWID) comprise 10-48% of male and 30-60% of female prisoners. The spread of hepatitis C in prisons is clearly driven by injection drug use, with many infected prisoners unaw...
Autores principales: | Arain, Amber, Robaeys, Geert, Stöver, Heino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178549/ https://www.ncbi.nlm.nih.gov/pubmed/25252822 http://dx.doi.org/10.1186/1471-2334-14-S6-S17 |
Ejemplares similares
Ejemplares similares
-
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries
por: Bielen, Rob, et al.
Publicado: (2018) -
Drug use and opioid substitution treatment for prisoners
por: Stöver, Heino, et al.
Publicado: (2010) -
Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study
por: Moazen, Babak, et al.
Publicado: (2021) -
The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases
por: Stöver, Heino, et al.
Publicado: (2021) -
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study
por: Robaeys, Geert, et al.
Publicado: (2017)